跳至主要内容
临床试验/ISRCTN74263041
ISRCTN74263041已完成未知

A randomised, controlled trial to compare the effects of systemic HRT (tibolone) and vaginal oestrogen (estring) upon the overactive bladder in postmenopausal women.

Department of Health0 个研究点目标入组 120 人开始时间: 2005年9月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 120 postmenopausal women aged 60 or over who are suffering from overactive bladder symptoms.

排除标准

  • 1. Women aged < 60 years
  • 2. Pre-menopausal women
  • 3. Women who have had a history of uncontrolled metabolic diseases, neurological conditions, permanent catheterisation, chronic urinary tract infections
  • 4. Patients who have any contraindications to the use of HRT
  • 5. Patients who have suffered a major prolapse (as defined by The International Continence Society)
  • 6. Patients who have taken hormone replacement therapy within the last 6 months

研究者

相似试验